Biotech Values

[DewDiligence]

>All these very expensive “miracle” drugs, yet no money to buy them.<

The way I like to phrase it is:

“There are too many cancer drugs and drug candidates chasing too few reimbursement dollars.”

All told, I think cancer is among the worst biotech sectors to invest in. I do it anyway, sometimes, but I try not to make a habit of it.